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SObjective: We sought to compare the long-term effects of conventional and simplified thoracic sympathectomy
on cardiopulmonary function.
Methods: We performed a prospective and randomized study of 32 patients with diagnoses of primary hyperhi-
drosis who were candidates for either conventional or simplified thoracic sympathectomy. Patients were random-
ized according to the type of procedure: conventional thoracic sympathectomy (18 patients) and simplified
thoracic sympathectomy (14 patients). Before surgical intervention, forced spirometry, body plethysmography,
measurement of the diffusing capacity of the lung for carbon monoxide (DLCO), and exercise tests were carried
out in all patients. These evaluations were performed again 1 year after the procedure to assess the long-term ef-
fects of sympathectomy.
Results: Lung function tests revealed a significant decrease in forced expiratory volume in 1 second (FEV1) and
forced expiratory flow between 25% and 75% of vital capacity (FEF25%–75%) in both groups (FEV1 of6.3% and
FEF25%–75% of9.1% in the conventional thoracic sympathectomy group and FEV1 of3.5% and FEF25%–75%
of12.3% in the simplified thoracic sympathectomy group). DLCO and heart rate at rest and maximal values after
exercise were also significantly reduced in both groups (DLCO of4.2%, DLCO corrected by alveolar volume of
6.1%, resting heart rate of11.8 beats/min, and maximal heart rate of9.5 beats/min in the conventional thoracic
sympathectomy group and DLCO of3.9%, DLCO corrected by alveolar volume of5.2%, resting heart rate of
10.7 beats/min, and maximal heart rate of17.6 beats/min in the simplified thoracic sympathectomy group). Airway
resistance increased significantly in the group of patients undergoing conventional thoracic sympathectomy (þ13%).
Despite all these changes, the patients remained asymptomatic. No significant differences were found between the
conventional and simplified thoracic sympathectomy groups.
Conclusions: Simplified and conventional thoracic sympathectomy resulted in a long-term reduction in FEV1,
FEF25%–75%, DLCO, and resting and maximal heart rate, as well as a mild but significant increase in airway re-
sistance in the conventional thoracic sympathectomy group, without any clinical consequence to the patient.
These changes were unrelated to the level of transection of the thoracic sympathetic chain. (J Thorac Cardiovasc
Surg 2010;139:405-10)Primary essential hyperhidrosis is a condition characterized
by excessive sweating. It affects primarily the hands (palmar
hyperhidrosis) but can extend to the feet (plantar hyperhidro-
sis) and axillae. Excessive sweating is defined as sweating that
exceeds physiologic needs.1 The current most accepted treat-
ment for hyperhidrosis is the excision of T2 and T3 sympa-
thetic ganglia in the palmar forms, whereas an additional
excision of T4 is recommended in axillary presentations.
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The Journal of Thoracic and Caleading to better outcomes and low morbidity/mortality,
have promoted thoracic sympathectomy as the treatment of
choice for hyperhidrosis. Compensatory hyperhidrosis is the
most common secondary effect,2 and it has been suggested
that it could be related to the extent of the sympathicolysis. In-
deed, some authors advocate a more selective and limited pro-
cedure (only at T3 level) to minimize this undesirable effect.3
Partial cardiopulmonary sympathetic denervation is a po-
tential consequence of the T2T4 thoracic sympathicolysis4
because sympathetic innervation for those organs derives
from the cervical and thoracic sympathetic chain.5 Very
few studies addressing the role of sympathetic innervation
of the human lung are currently available. The airway re-
ceives a dense cholinergic postganglionic innervation stem-
ming from the numerous parasympathetic ganglia located on
the airway wall.6 The sympathetic innervation is generally
rare and even controversial. However, by using electron mi-
croscopy, some studies have demonstrated the presence of
adrenergic nerves in the lower respiratory tract, although
at a much lower frequency than cholinergic fibers.7rdiovascular Surgery c Volume 139, Number 2 405
40
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SAbbreviations and Acronyms
DLCO ¼ diffusing capacity of the lung for
carbon monoxide
FEF25%–75% ¼ forced expiratory flow between
25% and 75% of vital capacity
FEV1 ¼ forced expiratory volume in
1 second
FVC ¼ forced vital capacity
KCO ¼ DLCO corrected by alveolar volume
Raw ¼ airway resistance
TLC ¼ total lung capacity
VE ¼ minute ventilation
VO2 ¼ oxygen uptake
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mVery few studies have examined the effect of upper
thoracic sympathectomy on cardiopulmonary function, and
they all focused on short-term and midterm effects (<6
months after the procedure).8-11 Our group has published
the first study on the long-term assessment of pulmonary
function by means of spirometry in sympathectomized pa-
tients 1 year after the operation. The results allowed us to
rule out that the observed reduction in respiratory volume
and flow was caused directly by the surgical technique.12
All studies published to date have only included patients op-
erated on with conventional sympathectomy (2 levels, T2
and T3). Therefore no results are available on pulmonary
function after simplified sympathectomy, a technique be-
lieved to be the safest and the one with the least secondary ef-
fects because it induces less compensatory hyperhidrosis.3,13
In this study we intended both to evaluate whether reducing
the extent of the transected sympathetic chain modifies the
cardiorespiratory functions in the long-term and to determine
whether such changes are correlated with the extent and level
of the sympathectomy.
MATERIALS AND METHODS
Patients
The study included 32 consecutive candidates for surgical treatment for
primary hyperhidrosis unresponsive to conservative management. Patients
were randomly selected to undergo either conventional or simplified sympa-
thectomy. Informed consent forms were provided to and signed by all par-
ticipants. The study was reviewed by the human subjects review committee
of our hospital. Patients with acute or chronic pulmonary diseases were ex-
cluded from the study. None of the patients was taking medication with car-
diopulmonary effects nor was a smoker.
Pulmonary Function Testing
Forced spirometry was carried out before and 1 year after surgical inter-
vention in all patients. The same spirometer was used throughout the study
(Master Screen; Jaeger, Wu¨rzburg, Germany), and the European Respira-
tory Society/American Thoracic Society consensus guidelines for pulmo-
nary function testing were followed.14 Recorded parameters were forced
vital capacity (FVC), forced expiratory volume in 1 second (FEV1), and
forced expiratory flow between 25% and 75% of vital capacity (FEF25%–
75%). Pulmonary volumes and airway resistance (Raw) were also measured6 The Journal of Thoracic and Cardiovascular Surgbefore and 1 year after the operation by using body plethysmography (Mas-
er Screen Body, Jaeger), according to the European Respiratory Society/
merican Thoracic Society consensus15; the recorded parameters were total
ung capacity (TLC), residual volume, inspiratory and expiratory reserve
olume, and Raw. All patients had measurements of diffusing capacity of
he lung for carbon monoxide (DLCO) before and 1 year after the operation.
gas analyzer (Jaeger Compact-transfer) was used to estimate the diffusing
apacity. The test consisted of inhalation of a gas mixture with known con-
entrations of 0.3% carbon monoxide, an inert gas (10% helium), 21%
xygen, and nitrogen, according to the American Thoracic Society
onsensus.16 The variables obtained were DLCO and DLCO corrected by al-
eolar volume (KCO). Finally, on a different day, an exercise test was per-
ormed with a cycloergometer (Jaeger Oxicon Delta). In all cases an
ncreasing-intensity, symptom-limited protocol from Jones17 was applied.
he test begins with a 3-minute resting period, after which the patient starts
edaling without resistance during the next 3 minutes. The patient should
aintain the same speed throughout the exercise (around 60 revolutions
per minute). Then resistance is gradually increased by 20 W each minute un-
til either maximal tolerance is reached or the appearance of signs or symp-
toms requires interruption of the exercise. The following main variables
were recorded at rest and at maximal effort: heart and respiratory rate, sys-
tolic and diastolic blood pressure, hemoglobin oxygen saturation, oxygen
uptake (VO2), carbon dioxide output, minute ventilation (VE), and continu-
ous electrocardiographic assessment.
Video-Assisted Thoracoscopic Sympathectomy
The surgical technique was performed after achievement of general anes-
thesia and selective bronchial intubation with a double-lumen endotracheal
tube. When a proper lung collapse was not possible, the procedure was car-
ried out during short apneas. The patient was placed in a sitting position at
90 with both arms in abduction. This position enables a good separation
of the lung parenchyma and the sympathetic chain, providing satisfactory vi-
sualization. Two incisions of 11 and 5 mm, respectively, on the medial and
anterior axillary lines were made, through which the endodissector (5 mm)
and the video endoscope (11 mm) were introduced. In women incisions
were aligned to the submammary line so as to achieve a better aesthetic result.
After a unilateral lung collapse, the paravertebral sympathetic chain was
identified, and the costal arches were localized. The sympathectomy on
the selected costal arches consisted of a section of the chain by means of elec-
trocoagulation. In patients with palmar hyperhidrosis, sympathectomy was
performed at the level of the third costal arch (T3) in the simplified technique
and the second and third arches (T2–T3) in the conventional technique. In
patients with palmar and axillary hyperhidrosis, sympathectomy was per-
formed on the third and fourth costal arches (T3–T4) in the simplified tech-
nique and on the second and fourth arches in the conventional procedure.
Once the sympathetic chain was transected, the correct denervation was ver-
ified by checking the increased skin temperature of the palms. After manual
expansion of the lung, a pleural drain was placed and connected to an aspi-
ration system until air was completely expelled from the pleural cavity. The
drain was then withdrawn, and both incisions were closed. A plain chest ra-
diograph was taken in the recovery room before patients were transferred to
the inpatient unit and discharged the day after the procedure.
Statistical Analysis
The pulmonary function data are expressed as means and standard devi-
ations. Comparisons between cardiopulmonary function results involved
nonparametric tests: the Wilcoxon test for paired values and the Mann–
Whitney U test for independent values. The statistical package SPSS ver-
sion 15.0 (SPSS, Inc, Chicago, Ill) was used.
RESULTS
The study population consisted of 20 female and 12 male
patients with a mean age of 25.44 years (range, 14–40ery c February 2010
TABLE 1. Changes in pulmonary function test, body plethysmography,
DLCO, and exercise test results in 18 patients with palmar or palmar and
axillary hyperhidrosis 12 months after conventional sympathectomy
(T2–T4 and T2–T3)
Parameters
Before the
operation
(mean ± SD)
Twelve months
after the
operation
(mean ± SD)
P
value
FVC (L) 4.43  0.81 4.30  1.11 NS
FVC (%) 105.7  12.6 101.7  26.2 NS
FEV1 (L) 3.65  0.89 3.42  0.79 <.05
FEV1 (%) 108.3  11.9 103.2  10.4 <.05
FEF25%–75% (L/s) 3.74  1.18 3.40  1.08 <.05
FEF25%–75% (%) 91.2  24.4 82.9  22.3 <.05
TLC (L) 5.86  1.21 5.81  1.17 NS
TLC (%) 111.43  14 110.7  12.8 NS
RV (L) 1.55  0.35 1.61  0.27 NS
RV (%) 118.3  30.9 119.8  27.7 NS
Raw (kPa $ s1 $ L1) 0.20  0.08 0.23  0.05 <.05
Raw (%) 81.2  36.1 78.9  23.4 NS
DLCO (mmol $ min1 $ kPa1) 9.26  2.77 8.87  2.8 <.05
KCO (mmol $ min1 $ kPa1 $ L1) 1.79  0.22 1.68  0.23 <.05
Resting VE (L/min) 12.08  5.9 11.1  4.63 NS
Peak VE (L/min) 80.92  37.9 86.1  29.6 NS
Peak VE (%) 79.7  25.1 80.8  17.9 NS
Resting VO2 (mL/min) 376.7  241.2 342.6  176.5 NS
Peak VO2 (mL/min) 2351.5  954.6 2385.1  846.6 NS
Peak VO2 (%) 88.8  9.7 92.7  12.3 NS
Resting HR (beats/min) 84.8  12.3 73  13.3 <.05
Peak HR (beats/min) 172.2  17.4 162.7  16.9 <.05
DLCO, Diffusing capacity of the lung for carbon monoxide; SD, Standard deviation
FVC, forced vital capacity; NS, not significant; FEV1, forced expiratory volume in 1
second; FEF25%–75%, forced expiratory flow at 25% to 75% of vital capacity; TLC,
total lung capacity; RV, residual volume; Raw, airway resistance; KCO, DLCO corrected
by alveolar volume; VE, minute ventilation; VO2, oxygen uptake; HR, heart rate.
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which confirmed the actual interruption of the sympathetic
chain and therefore the hypothetical partial cardiopulmonary
denervation. None of the patients experienced cardiorespira-
tory complications after the operation, except for 1 patient
with transient Horner’s syndrome.
Results of spirometric testing, body plethysmography,
DLCO, and cardiopulmonary ergometry were within the nor-
mal ranges before the operation. To analyze the results, pa-
tients were grouped according to the type of the procedure:
conventional sympathectomy (18 patients; 3 or 2 levels, T2–
T4 or T2–T3) and simplified sympathectomy (14 patients; 2
levels or 1 level, T3–T4 or only T3; Tables 1 and 2). Signif-
icant reductions in forced spirometric values were observed
for FEV1 and FEF25%–75% in both groups 1 year after the
operation (conventional sympathectomy: FEV1 of 0.230 L
[5.1%] and FEF25%–75% of 0.340 L/s [8.3%]; simplified
sympathectomy: FEV1 of 0.130 L [2.8%] and FEF25%–75%
of 0.540 L/s [7.4%]). There were no significant differences
in FVC for any group. Regarding body plethysmography,
DLCO measurement, and exercise testing 1 year after the pro-
cedure, patients in the conventional technique group pre-
sented with a significant increase in Raw: 0.03 kPa $ s1 $
L1 (þ13%). A significant reduction in DLCO and KCO values
was also observed (conventional sympathectomy: DLCO of
0.39 mmol $ min1 $ kPa1 [4.2%] and KCO of 0.11
mmol $ min1 $ kPa1 $ L1 [6.1%]; simplified sympathec-
tomy: DLCO of 0.35 mmol $ min1 $ kPa1 [3.9%] and KCO
of 0.09 mmol $ min1 $ kPa1 $ L1 [5.2%]). However, the
values for TLC and residual volume did not change signifi-
cantly, nor did Raw values change in the simplified sympa-
thectomy group. Cardiorespiratory ergometry results
exhibited a significant reduction in resting and maximal
heart rate in both groups (conventional sympathectomy:
resting heart rate of 11.8 beats/min and maximal heart rate
of 9.5 beats/min; simplified sympathectomy: resting heart
rate of 10.7 beats/min and maximal heart rate of 17.6
beats/min). No differences were observed at rest or after
maximal effort in VO2 or in VE. The cardiopulmonary func-
tion tests carried out did not show any significant difference
between patients submitted to conventional or simplified
sympathectomy (Table 3). The stratification of patients ac-
cording to the levels of denervation did not reveal further dif-
ferences when comparisons were performed between the
following interventions: T2 (T2–T4 and T2–T3) versus
non-T2 (T3 and T3–T4); only 1 level (T3) versus 2 or 3
levels (T2–T3, T3–T4, or T2–T4); and T4 (T2–T4 and
T3–T4) versus non-T4 (T3 and T2–T3). After 1 year of fol-
low-up, all patients remained asymptomatic.
DISCUSSION
There are very few studies that describe the changes in pul-
monary function after sympathectomy and evaluate the role
of the simplified technique. Such studies have assessedThe Journal of Thoracic and Cashort-term and midterm pulmonary changes (1, 3, and 6
months) after sympathectomy.8-11 The first 2 investigations,
published by Molho and colleagues8 in the 1970s and 1980s,
compared sympathectomies using either supraclavicular or
transaxillary thoracotomy. They observed a reduction in pul-
monary volumes and flows at 3 weeks and 3 and 6 months
after surgical intervention. In a previous study we assessed
the long-term effects of thoracoscopic sympathectomy on
pulmonary function (1 year after the operation), and we dem-
onstrated a sustained and significant decrease in FEV1 and
FEF25%–75%.
12 These data confirmed that partial sympa-
thetic denervation in patients with hyperhidrosis results in
a disturbance of bronchomotor tone and supported the role
of the sympathetic nervous system in respiratory function.
Given the controversial role of the sympathetic nervous
system in cardiorespiratory function, we aimed at further
characterizing it by taking advantage of various surgical
sympathectomy approaches. In this case we decided to com-
pare patients undergoing conventional versus simplified
sympathectomy on the hypothesis that a more limited sec-
tion of the sympathetic chain would have less negativerdiovascular Surgery c Volume 139, Number 2 407
TABLE 2. Changes in pulmonary function test, body plethysmography,
DLCO, and exercise test results in 14 patients with palmar or palmar and
axillary hyperhidrosis 12 months after simplified sympathectomy
(T3–T4 and T3)
Parameters
Before the
operation
(mean ± SD)
Twelve months
after the
operation
(mean ± SD)
P
value
FVC (L) 4.41  0.81 4.31  1.1 NS
FVC (%) 104.5  8.9 102.7  10.9 NS
FEV1 (L) 3.64  0.88 3.51  0.8 <.05
FEV1 (%) 106.5  10.6 103.7  9.8 <.05
FEF25%–75% (L/s) 4.36  1.65 3.82  1.2 <.05
FEF25%–75% (%) 89  36.8 81.6  26.1 <.05
TLC (L) 5.80  1.1 5.77  1.2 NS
TLC (%) 105.1  9.7 103.9  9.2 NS
RV (L) 1.58  0.3 1.54  0.4 NS
RV (%) 108.1  20.4 104.2  24 NS
Raw (kPa $ s1 $ L1) 0.20  0.05 0.22  0.07 NS
Raw (%) 68.3  20.8 73.1  21.5 NS
DLCO (mmol $ min1 $ kPa1) 8.83  2.5 8.48  2.5 <.05
KCO (mmol $ min1 $ kPa1 $ L1) 1.72  0.2 1.63  0.2 <.05
Resting VE (L/min) 9.87  2.20 11.8  4 NS
Peak VE (L/min) 85.3  23.1 77.9  23.3 NS
Peak VE (%) 85.6  16 78.6  13.5 NS
Resting VO2 (mL/min) 309.2  79.8 356.3  128.5 NS
Peak VO2 (mL/min) 2298. 1  782.4 2222.1  717.9 NS
Peak VO2 (%) 93.5  13.8 91.8  15 NS
Resting HR (beats/min) 89.7  20.1 79  15 <.05
Peak HR (beats/min) 179  19.6 161.4  29.8 <.05
DLCO, Diffusing capacity of the lung for carbon monoxide; SD, Standard deviation
FVC, forced vital capacity; NS, not significant; FEV1, forced expiratory volume in 1
second; FEF25%–75%, forced expiratory flow at 25% to 75% of vital capacity; TLC,
total lung capacity; RV, residual volume; Raw, airway resistance; KCO, DLCO corrected
by alveolar volume; VE, minute ventilation; VO2, oxygen uptake; HR, heart rate.
TABLE 3. Comparison of the changes in pulmonary function test,
body plethysmography, DLCO, and exercise test results 12 months
after surgical intervention in patients undergoing conventional (n ¼
18) or simplified (n ¼ 14) sympathectomy
Conventional
(mean ± SD)
Simplified
(mean ± SD)
P
value
FVC (L) 4.30  1.11 4.31  1.1 NS
FVC (%) 101.7  26.2 102.7  10.9 NS
FEV1 (L) 3.42  0.79 3.51  0.8 NS
FEV1 (%) 103.2  10.4 103.7  9.8 NS
FEF25%–75% (L/s) 3.40  1.08 3.82  1.2 NS
FEF25%–75% (%) 82.9  22.3 81.6  26.1 NS
TLC (L) 5.81  1.17 5.77  1.2 NS
TLC (%) 110.7  12.8 103.9  9.2 NS
RV (L) 1.61  0.27 1.54  0.4 NS
RV (%) 119.8  27.7 104.2  24 NS
Raw (kPa $ s1 $ L1) 0.23  0.05 0.22  0.07 NS
Raw (%) 78.9  23.4 73.1  21.5 NS
DLCO (mmol $ min1 $ kPa1) 8.87  2.8 8.48  2.5 NS
KCO (mmol $ min1 $ kPa1 $ L1) 1.68  0.23 1.63  0.2 NS
Resting VE (L/min) 11.1  4.63 11.8  4 NS
Peak VE (L/min) 86.1  29.6 77.9  23.3 NS
Peak VE (%) 80.8  17.9 78.6  13.5 NS
Resting VO2 (mL/min) 342.6  176.5 356.3  128.5 NS
Peak VO2 (mL/min) 2385.1  846.6 2222.1  717.9 NS
Peak VO2 (%) 92.7  12.3 91.8  15 NS
Resting HR (beats/min) 73  13.3 79  15 NS
Peak HR (beats/min) 162.7  16.9 161.4  29.8 NS
DLCO, Diffusing capacity of the lung for carbon monoxide; SD, Standard deviation
FVC, forced vital capacity; NS, not significant; FEV1, forced expiratory volume in 1
second; FEF25%–75%, forced expiratory flow at 25% to 75% of vital capacity; TLC,
total lung capacity; RV, residual volume; Raw, airway resistance; KCO, DLCO corrected
by alveolar volume; VE, minute ventilation; VO2, oxygen uptake; HR, heart rate.
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hyperhidrosis. The results revealed a significant reduction in
FEV1 and FEF25%–75% 1 year after surgical intervention in
patients subjected to conventional sympathectomy (with 2-
or 3-level sections), as well as in patients undergoing the
simplified procedure (with 1- or 2-level sections). It could
be considered that the decrease in FEV1 and FEF25%–75%
is due to the passage of time. In this regard Fletcher and
Peto18 showed that the decrease in FEV1 according to age
is about 25 to 30 mL per year, on average. However, we
found that the mean change in FEV1 in the conventional
sympathectomy group was 230 mL, and that in the simpli-
fied sympathectomy group was 130 mL. Moreover, the
yearly decrease in FEV1 observed in the whole population
increases with age.18 Probably in our young population
a normal reduction is less than 25 to 30 mL.
Another cause that could explain the changes in lung
function is the effects of the surgical procedure on the chest
wall. If this were true, we would have mainly expected a de-
crease in FVC or TLC. In our study neither of these param-
eters was significantly reduced, suggesting that the decrease408 The Journal of Thoracic and Cardiovascular Surgin FEV1 and FEF25%–75% reflects an alteration in broncho-
motor tone. Furrer and associates19 studied pulmonary func-
tion after thoracic surgery (thoracotomy and thoracoscopy).
They showed a reduction in FVC and FEV1 that returned to
normal 4 months after the procedure. In our study the mea-
surement of lung function was carried out a year after the op-
eration, making it unlikely that such a decrease could be
attributed to the technique.
This study has also included the measurement of lung vol-
ume, Raw, DLCO, and cardiocirculatory response to exercise.
We performed these tests 1 year after the surgical procedure,
as in our first study. No significant differences were found in
lung volume; however, the significant increase in Raw in the
conventional method group along with a decrease in FEV1
and FEF25%–75% suggested a role of the sympathetic ner-
vous system on bronchomotor tone. We did not find any dif-
ferences in Raw in the group of patients treated with the
simplified method. However, the small size of the sample
in our study (14 patients) could account for this observation.
The influence of the autonomous nervous system on DLCO
is poorly understood. Noppen and Vincken20 studied theery c February 2010
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6 weeks after surgical intervention and found a significant
reduction in pulmonary DLCO (DLCO,6.7%; KCO,4.2%).
Our results confirmed that DLCO significantly decreases in
patients undergoing either conventional or simplified sympa-
thectomy and that this decrease persists 1 year after the
procedure. It appears unlikely that this significant reduction
in pulmonary diffusion capacity is due to a decrease in
TLC because the latter was virtually negligible (<0.1 L) in
both groups. These findings indicate that the sympathetic
nervous system not only plays a role in the regulation of bron-
chomotor tone but also in the long-term diffusion capacity of
the lung. The mechanisms underlying these changes could be
multiple. Noppen and Vincken20 proposed an alteration in
blood flow (caused by perturbed pulmonary vasoconstric-
tion) that would enhance lung capillary permeability, leading
to an increase in total interstitial fluid and to changes in the
composition and thickness of the alveolar–capillary mem-
brane. Another potential explanation is that the decrease in
vascular tone generated by the partial sympathetic denerva-
tion of the lung, along with the increase in bronchomotor
tone, leads to the reduction in DLCO.
Regarding the cardiorespiratory ergometry, Noppen and
coworkers4 also studied patients subjected to thoracic sym-
pathectomy only 1 month after surgical intervention. They
demonstrated that the procedure induces significant modifi-
cations of cardiac function as measured by heart rate both at
rest and in response to exercise without detecting changes in
VO2 uptake. However, a reduction in VO2 after surgical inter-
vention was found by Papa and colleagues21 in patients sub-
jected to sympathectomy by means of thoracotomy; this
decrease in oxygen intake could be explained by the thora-
cotomy itself. In another recent study Vigil and associates11
observed in 20 patients 3 months after surgical intervention
that only maximal heart rate after exercise was affected, with
heart rate at rest unchanged. Our results showed significant
differences in both values in patients undergoing either con-
ventional or simplified sympathectomy. In consequence,
there seems to be evidence that sympathectomy entails not
only partial denervation of the lung but also of the heart. In-
deed, upper thoracic sympathectomy has been investigated
in the treatment of angina, ventricular tachycardia, and ar-
rhythmias associated with the long QT syndrome.22 Several
studies have also demonstrated decreased plasma levels of
noradrenaline in patients undergoing sympathectomy.23 Be-
cause no differences were found in our study between ap-
proaches including T2 and the others levels, we suggest
that the removal of any of these levels (T2, T3, or T4) will
have a similar effect on heart rate.
We did not detect any difference in cardiopulmonary
function between patients undergoing conventional or sim-
plified sympathectomy. Therefore the reduction in the
amount of sympathetic nervous fibers sectioned when a sim-
plified sympathectomy is carried out does not seem to impli-The Journal of Thoracic and Cacate a less significant decrease in pulmonary or cardiac
function. The cervicothoracic branches, which have the ca-
pacity to innervate the bronchial tree and stay put after the
simplified sympathectomy, could account for this observa-
tion.5 The likely existence of the so-called nerves of Kuntz,
whose sympathetic connections avoid the second and third
ganglia, thus directly connecting to the brachial plexus and
perhaps conveying nervous fascicles to the bronchial tree,
should be mentioned.24 In any case it is worth emphasizing
a trend that points to a lesser reduction in lung volumes and
flows in patients undergoing simplified sympathectomy who
were hypothetically subjected to a less important sympa-
thetic denervation. A larger sample size will be necessary
to confirm this tendency.
This is the first study assessing the long-term effects of
sympathectomy on cardiopulmonary function and compar-
ing the conventional and simplified techniques. The results
suggest that sympathectomy induces long-term modifica-
tions on cardiopulmonary function, revealing the effect of
the sympathetic nervous system on this apparatus, at least
in patients with primary hyperhidrosis. It has been demon-
strated that both surgical techniques are safe in the long-
term because we observed minimal and clinically irrelevant
reductions in FEV1, FEF25%–75%, Raw, DLCO, and at-rest
and maximal heart rate. Furthermore, the fact that a decrease
in peak VO2 was not found might indicate that the observed
changes do not affect performance during maximal exercise.
These modifications are independent of the extent and level
of the transection of the sympathetic chain because they ap-
pear in patients undergoing both conventional and simplified
sympathectomy.References
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